Fmoc-2,3-Difluoro-L-Phenylalanine is a non-natural, fluorinated amino acid derivative. Its chemical structure features an L-phenylalanine backbone with fluorine atoms at the 2- and 3-positions of the phenyl ring, and the amine group is protected by a 9-fluorenylmethoxycarbonyl (Fmoc) group. This compound is a white to off-white solid powder. This derivative is a crucial building block in solid-phase peptide synthesis (SPPS) using the Fmoc strategy. The fluorine atoms on the aromatic ring introduce unique electronic and steric properties, which can significantly alter the peptide's conformation, metabolic stability, lipophilicity, and binding affinity to biological targets. It is extensively used in medicinal chemistry research for the development of novel peptide-based therapeutics, including protease inhibitors, receptor agonists/antagonists, and diagnostic agents. The Fmoc protecting group is readily cleaved under mild basic conditions, making it compatible with automated peptide synthesizers. Its primary application lies in the research and development of pharmaceutical peptides where the incorporation of fluorinated amino acids is desired to enhance pharmacological properties.